Correlation Between ULTRA CLEAN and Diamyd Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ULTRA CLEAN and Diamyd Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ULTRA CLEAN and Diamyd Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ULTRA CLEAN HLDGS and Diamyd Medical AB, you can compare the effects of market volatilities on ULTRA CLEAN and Diamyd Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ULTRA CLEAN with a short position of Diamyd Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ULTRA CLEAN and Diamyd Medical.

Diversification Opportunities for ULTRA CLEAN and Diamyd Medical

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between ULTRA and Diamyd is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding ULTRA CLEAN HLDGS and Diamyd Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diamyd Medical AB and ULTRA CLEAN is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ULTRA CLEAN HLDGS are associated (or correlated) with Diamyd Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diamyd Medical AB has no effect on the direction of ULTRA CLEAN i.e., ULTRA CLEAN and Diamyd Medical go up and down completely randomly.

Pair Corralation between ULTRA CLEAN and Diamyd Medical

Assuming the 90 days trading horizon ULTRA CLEAN is expected to generate 2.33 times less return on investment than Diamyd Medical. But when comparing it to its historical volatility, ULTRA CLEAN HLDGS is 1.93 times less risky than Diamyd Medical. It trades about 0.02 of its potential returns per unit of risk. Diamyd Medical AB is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  137.00  in Diamyd Medical AB on September 3, 2024 and sell it today you would lose (25.00) from holding Diamyd Medical AB or give up 18.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ULTRA CLEAN HLDGS  vs.  Diamyd Medical AB

 Performance 
       Timeline  
ULTRA CLEAN HLDGS 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in ULTRA CLEAN HLDGS are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, ULTRA CLEAN exhibited solid returns over the last few months and may actually be approaching a breakup point.
Diamyd Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

ULTRA CLEAN and Diamyd Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ULTRA CLEAN and Diamyd Medical

The main advantage of trading using opposite ULTRA CLEAN and Diamyd Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ULTRA CLEAN position performs unexpectedly, Diamyd Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will offset losses from the drop in Diamyd Medical's long position.
The idea behind ULTRA CLEAN HLDGS and Diamyd Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format